Articles tagged with Activated Platelets
Researchers at Würzburg University discovered a new approach to preventing thrombosis by reducing the density of GPVI receptors on platelets. This 'GPVI-low' phenotype maintains haemostatic function while inhibiting blood clot formation, offering a safer alternative to current treatments.
Researchers found a link between platelet aggregation and Alzheimer's biomarkers in midlife, suggesting a potential early warning sign. The study analyzed 382 participants and found that stronger platelet clumping was associated with higher levels of amyloid and tau proteins.
Researchers at EHU developed a portable, cost-effective system for generating high-quality platelet-rich plasma (PRP), minimizing platelet activation and preserving therapeutic efficacy. The device uses gravity sedimentation and can extract up to 300 micro-liters of PRP from 1 milliliter of blood in just 40 minutes.
A novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods currently in use. The technology has the potential to assess the effects of antiplatelet drugs on individuals and gain a clearer picture of bleeding risks for patients undergoing cardiopulmonary bypass surgery.
Researchers developed a fluorescent probe that binds to activated platelets, enabling clinicians to proactively treat patients before clotting or scarring occurs. The tool uses intravascular catheter-based imaging and has the potential to optimize patient outcomes.
Researchers found platelet Golgi apparatus undergoes changes after acute cerebral infarction, influencing CD40L expression and platelet function. This discovery may lead to new therapeutic targets for treating cerebral infarctions.
Researchers have developed a new method to detect activated platelets in the brain of mice with cerebral malaria, allowing for earlier diagnosis. The use of a specific single-chain antibody and iron oxide microparticles enables detection by MRI, potentially leading to improved therapeutic and diagnostic strategies.
Researchers found activated platelets can deposit pro-inflammatory factors on monocytes and vessel walls, contributing to atherosclerotic lesions. The study suggests that targeting platelet P-selectin may be an effective way to limit the formation of these lesions.